Stockreport

MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer

MAIA Biotechnology, Inc.  (MAIA) 
PDF Expansion of 2021 clinical supply agreement for Phase 2 clinical trialNext stage of trial to further assess efficacy of THIO in third line non-small cell lung cancer pat [Read more]